These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8765195)
41. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583 [TBL] [Abstract][Full Text] [Related]
42. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Anania CA; Stewart EA; Quade BJ; Hill JA; Nowak RA Mol Hum Reprod; 1997 Aug; 3(8):685-91. PubMed ID: 9294852 [TBL] [Abstract][Full Text] [Related]
43. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Jovanovic AS; Boynton KA; Mutter GL Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514 [TBL] [Abstract][Full Text] [Related]
44. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers. Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T Ann Oncol; 2002 Oct; 13(10):1605-11. PubMed ID: 12377649 [TBL] [Abstract][Full Text] [Related]
45. [Angiogenesis related gene expression profiles of human endometrial endothelial cells isolated from tissue of endometrial cancer]. Du XL; Sheng XG; Yan CX; Liu T; Wang C; Song QQ; Li QS Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):756-63. PubMed ID: 23302734 [TBL] [Abstract][Full Text] [Related]
46. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers. Fujimoto J; Aoki I; Khatun S; Toyoki H; Tamaya T Ann Oncol; 2002 Mar; 13(3):430-4. PubMed ID: 11996475 [TBL] [Abstract][Full Text] [Related]
47. Expression of aberrant estrogen receptor mRNA in endometrial cancers in comparison with normal endometria. Fujimoto J; Hori M; Ichigo S; Nishigaki M; Itoh T; Tamaya T Horm Res; 1994; 42(3):116-9. PubMed ID: 7995615 [TBL] [Abstract][Full Text] [Related]
48. The proto-oncogene c-fms is overexpressed in endometrial cancer. Leiserowitz GS; Harris SA; Subramaniam M; Keeney GL; Podratz KC; Spelsberg TC Gynecol Oncol; 1993 May; 49(2):190-6. PubMed ID: 8504987 [TBL] [Abstract][Full Text] [Related]
49. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: implications for the neovascularization of normal and neoplastic endometrium. Presta M J Cell Physiol; 1988 Dec; 137(3):593-7. PubMed ID: 2461382 [TBL] [Abstract][Full Text] [Related]
50. The role of mast cells and angiogenesis in benign and malignant neoplasms of the uterus. Goksu Erol AY; Tokyol C; Ozdemir O; Yilmazer M; Arioz TD; Aktepe F Pathol Res Pract; 2011 Oct; 207(10):618-22. PubMed ID: 21820813 [TBL] [Abstract][Full Text] [Related]
51. Expression of sex hormone-binding globulin mRNA in human endometrial cancers. Misao R; Nakanishi Y; Ichigo S; Hori M; Fujimoto J; Tamaya T J Steroid Biochem Mol Biol; 1995 Jun; 52(6):517-22. PubMed ID: 7779755 [TBL] [Abstract][Full Text] [Related]
52. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer. Yoshida S; Harada T; Iwabe T; Taniguchi F; Fujii A; Sakamoto Y; Yamauchi N; Shiota G; Terakawa N J Clin Endocrinol Metab; 2002 May; 87(5):2376-83. PubMed ID: 11994390 [TBL] [Abstract][Full Text] [Related]
53. Expression of corticosteroid-binding globulin mRNA in human uterine endometrial cancers. Misao R; Nakanishi Y; Fujimoto J; Ichigo S; Hori M; Tamaya T Steroids; 1995 Oct; 60(10):720-4. PubMed ID: 8539782 [TBL] [Abstract][Full Text] [Related]
55. Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells. Fujimoto J; Hori M; Ichigo S; Tamaya T Eur J Gynaecol Oncol; 1997; 18(6):497-501. PubMed ID: 9443020 [TBL] [Abstract][Full Text] [Related]
56. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Fujimoto J; Sakaguchi H; Aoki I; Toyoki H; Tamaya T Oncology; 2002; 62(3):269-77. PubMed ID: 12065875 [TBL] [Abstract][Full Text] [Related]
57. Three-dimensional power Doppler angiography in endometrial cancer: correlation with tumor characteristics. Galván R; Mercé L; Jurado M; Mínguez JA; López-García G; Alcázar JL Ultrasound Obstet Gynecol; 2010 Jun; 35(6):723-9. PubMed ID: 20336639 [TBL] [Abstract][Full Text] [Related]
58. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects. Misao R; Nakanishi Y; Fujimoto J; Tamaya T Gynecol Endocrinol; 1995 Dec; 9(4):317-23. PubMed ID: 8629461 [TBL] [Abstract][Full Text] [Related]
59. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Khorram O; Garthwaite M; Grosen E; Golos T Fertil Steril; 2001 Jan; 75(1):174-9. PubMed ID: 11163834 [TBL] [Abstract][Full Text] [Related]
60. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Iurlaro M; Loverro G; Vacca A; Cormio G; Ribatti D; Minischetti M; Ria R; Bruno M; Selvaggi L Eur J Clin Invest; 1999 Sep; 29(9):793-801. PubMed ID: 10469168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]